Study of the Role of Genetic Modifiers in Hemoglobinopathies

Recruiting now

Conditions studied: Sickle Cell Disease, Thalassemia, Beta, Thalassemia Alpha, Hemoglobinopathies

In brief

This study will investigate the role of genetic modifiers in hemoglobinopathies through a large-scale, multi-ethnic genome-wide association study (GWAS).

Key facts

Study ID
NCT05799118
Run by
Cyprus Institute of Neurology and Genetics
People needed
30000
Starts
2022-10-01
Expected to finish
2027-09-30
Last updated by the study team
2024-03-20

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.